A Phase 1, Single Centre, Three-part, Randomised, Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Ascending Doses of Oral ONO-4053 and the Effects of Food on This Profile in Healthy Male and Female Subjects.

Trial Profile

A Phase 1, Single Centre, Three-part, Randomised, Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Ascending Doses of Oral ONO-4053 and the Effects of Food on This Profile in Healthy Male and Female Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2012

At a glance

  • Drugs ONO 4053 (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jan 2012 Actual patients number (15) added as reported by ClinicalTrials.gov.
    • 24 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
    • 24 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top